文献速递心境障碍儿童青少年精神

认知行为疗法治疗抑郁:409项试验的综合荟萃分析

Cognitive behavior therapy vs. control conditions, other psychotherapies, pharmacotherapies and combined treatment for depression: a comprehensive meta-analysis including 409 trials with 52,702 patients.
PubMed 文献 · World Psychiatry · 2023-01-01

该研究纳入409项随机试验共52,702例抑郁患者,比较认知行为疗法(CBT)与对照条件、其他心理治疗、药物治疗及联合治疗的效果。结果显示CBT对照条件效应量为g=0.79,短期与药物相当但6-12个月随访时优于药物,联合治疗不优于单用CBT。

要点

  • CBT对照条件效应量g=0.79,6-12个月随访仍显著。
  • CBT短期与药物疗效无显著差异,6-12个月随访优于药物。
  • 联合治疗优于单用药物,但不优于单用CBT。

核心结论

  • CBT对抑郁的疗效在不同形式、年龄、目标人群和机构环境中均得到证实。
  • CBT优于其他心理治疗的证据不明确。
  • CBT短期与药物相当,但6-12个月随访时优于药物。

研究设计与样本

  • 检索PubMed、PsycINFO、Embase和Cochrane Library,纳入409项随机试验共52,702例患者,进行随机效应荟萃分析。
  • 将试验分为多个亚组,分别比较CBT与对照条件、其他心理治疗、药物治疗及联合治疗。

主要发现

  • CBT对照条件(常规照护和等待名单)效应量g=0.79(95%CI 0.70-0.89),6-12个月随访仍显著。
  • CBT与其他心理治疗差异小(g=0.06;95%CI 0-0.12),多数敏感性分析中不显著。
  • CBT短期与药物无显著差异,6-12个月随访时CBT优于药物(g=0.34;95%CI 0.09-0.58),但试验数少且部分敏感性分析不显著。
  • 联合治疗短期(g=0.51;95%CI 0.19-0.84)和长期(g=0.32;95%CI 0.09-0.55)优于单用药物,但不优于单用CBT。
  • CBT作为无指导自助干预(g=0.45;95%CI 0.31-0.60)、机构环境(g=0.65;95%CI 0.21-1.08)及儿童青少年(g=0.41;95%CI 0.25-0.57)均有效。

关键数值与推荐

  • CBT对照条件效应量g=0.79(95%CI 0.70-0.89)。
  • CBT与其他心理治疗差异g=0.06(95%CI 0-0.12)。
  • CBT与药物6-12个月随访差异g=0.34(95%CI 0.09-0.58)。
  • 联合治疗与单用药物短期差异g=0.51(95%CI 0.19-0.84),长期差异g=0.32(95%CI 0.09-0.55)。

临床怎么用

  • CBT可作为抑郁的一线心理治疗选择,在不同形式和人群中均可应用。
  • 短期治疗中CBT与药物疗效相当,长期随访中CBT可能更具优势。
  • 联合治疗不优于单用CBT,单用CBT可作为联合治疗的替代选择。

局限性

  • CBT优于其他心理治疗的差异小且多数敏感性分析不显著, superiority不明确。
  • CBT与药物长期比较的试验数量少,且差异并非所有敏感性分析中均显著。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Cognitive behavior therapy (CBT) is by far the most examined type of psychological treatment for depression and is recommended in most treatment guide-lines. However, no recent meta-analysis has integrated the results of randomized trials examining its effects, and its efficacy in comparison with other psychotherapies, pharmacotherapies and combined treatment for depression remains uncertain. We searched PubMed, PsycINFO, Embase and the Cochrane Library to identify studies on CBT, and separated included trials into several subsets to conduct random-effects meta-analyses. We included 409 trials (518 comparisons) with 52,702 patients, thus conducting the largest meta-analysis ever of a specific type of psychotherapy for a mental disorder. The quality of the trials was found to have increased significantly over time (with increasing numbers of trials with low risk of bias, less waitlist control groups, and larger sample sizes). CBT had moderate to large effects compared to control conditions such as care as usual and waitlist (g=0.79; 95% CI: 0.70-0.89), which remained similar in sensitivity analyses and were still significant at 6-12 month follow-up. There was no reduction of the effect size of CBT according to the publication year (<2001 vs. 2001-2010 vs. >2011). CBT was significantly more effective than other psychotherapies, but the difference was small (g=0.06; 95% CI: 0-0.12) and became non-significant in most sensitivity analyses. The effects of CBT did not differ significantly from those of pharmacotherapies at the short term, but were significantly larger at 6-12 month follow-up (g=0.34; 95% CI: 0.09-0.58), although the number of trials was small, and the difference was not significant in all sensitivity analyses. Combined treatment was more effective than pharmacotherapies alone at the short (g=0.51; 95% CI: 0.19-0.84) and long term (g=0.32; 95% CI: 0.09-0.55), but it was not more effective than CBT alone at either time point. CBT was also effective as unguided self-help intervention (g=0.45; 95% CI: 0.31-0.60), in institutional settings (g=0.65; 95% CI: 0.21-1.08), and in children and adolescents (g=0.41; 95% CI: 0.25-0.57). We can conclude that the efficacy of CBT in depression is documented across different formats, ages, target groups, and settings. However, the superiority of CBT over other psychotherapies for depression does not emerge clearly from this meta-analysis. CBT appears to be as effective as pharmacotherapies at the short term, but more effective at the longer term.

来源:World Psychiatry,查看原文。版权归原作者所有。

引用

  1. Cuijpers P, Miguel C, Harrer M, et al. Cognitive behavior therapy vs. control conditions, other psychotherapies, pharmacotherapies and combined treatment for depression: a comprehensive meta-analysis including 409 trials with 52,702 patients. World Psychiatry. 2023. PMID: 36640411. doi:10.1002/wps.21069

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。